UK resources in the care of adults with Down’s syndrome von Marder, Liz, Coghlan, J G

Volltext

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach von Mukerjee, D, St George, D, Coleiro, B, Knight, C, Denton, C P, Davar, J, Black, C M, Coghlan, J G

Volltext

Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension von Condliffe, R, Kiely, D. G, Gibbs, J. S. R, Corris, P. A, Peacock, A. J, Jenkins, D. P, Goldsmith, K, Coghlan, J. G, Pepke-Zaba, J

Volltext

How should we assess right ventricular function in 2008? von Coghlan, J.G., Davar, J.

Volltext

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era von Williams, M H, Das, C, Handler, C E, Akram, M R, Davar, J, Denton, C P, Smith, C J, Black, C M, Coghlan, J G

Volltext

Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study von Nihtyanova, S.I., Tang, E.C., Coghlan, J.G., Wells, A.U., Black, C.M., Denton, C.P.

Volltext

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis von Mukerjee, D., St. George, D., Knight, C., Davar, J., Wells, A. U., Du Bois, R. M., Black, C. M., Coghlan, J. G.

Volltext

Screening for pulmonary hypertension: reply von Coghlan, J G

Volltext

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism von Hachulla, E, Coghlan, J G

Volltext

Safety and feasibility audit of a home-based drug-transitioning approach for patients with pulmonary arterial hypertension: an observational study von Dawson, A, Reddecliffe, S, Coghlan, C, Schreiber, BE, Coghlan, JG

Volltext

Screening for pulmonary arterial hypertension in systemic sclerosis von Vachiery, J-L, Coghlan, G

Volltext

Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertension von Coghlan, JG, Denton, Christopher P.

Volltext

Angiographically proven coronary artery disease in scleroderma von AKRAM, M. R, HANDLER, C. E, WILLIAMS, M, CARULLI, M. T, ANDRON, M, BLACK, C. M, DENTON, C. P, COGHLAN, J. G

Volltext

Combined Pulmonary Fibrosis and Emphysema in Scleroderma‐Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension von Antoniou, K. M., Margaritopoulos, G. A., Goh, N. S., Karagiannis, K., Desai, S. R., Nicholson, A. G., Siafakas, N. M., Coghlan, J. G., Denton, C. P., Hansell, D. M., Wells, A. U.

Volltext

Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis? von Carulli, M T, Handler, C, Coghlan, J G, Black, C M, Denton, C P

Volltext

Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension von Mukerjee, D, Yap, L.B, Holmes, A.M, Nair, D, Ayrton, P, Black, C.M, Coghlan, J.G

Volltext

The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology von Coghlan, J G, Mukerjee, Dev

Volltext

Connective tissue associated pulmonary arterial hypertension von Coghlan, J G, Handler, C

Volltext

The myth of pulmonary Raynaud’s phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension von Mukerjee, D, Yap, L B, Ong, V, Denton, C P, Howells, K, Black, C M, Coghlan, J G

Volltext

Scleroderma and breast implants von Hong, C, Sangle, S R, Coghlan, J G, D'Cruz, D P

Volltext